Dr. Angèle Maki is a business development executive with fourteen years of deal-making experience spanning small biotech and big pharma. She is currently an Executive Director of Business Development & Licensing at Merck & Co. where she leads West Coast search & evaluation efforts in oncology and immunology. Prior to Merck, Angèle has held business development roles with increasing responsibility starting at Medarex followed by BMS and Genentech. During her career, she has successfully negotiated numerous in- and out-licensing transactions, from early-stage research technologies to clinical-stage assets.
Angèle has a Ph.D. in biological chemistry from Stanford University and completed postdoctoral work in molecular biology at the Scripps Research Institute in La Jolla. She completed her B.Sc. in chemistry at the University of Winnipeg in Canada.